Research Paper Volume 15, Issue 5 pp 1628—1651
Integrative analysis to screen novel pyroptosis-related LncRNAs for predicting clinical outcome of glioma and validation in tumor tissue
Figure 1. Construction and validation of the 46 pyroptosis-related lncRNA (PRLs) signature in Glioma patients. (A) Correlations between PRLs and pyroptosis regulator for glioma (Pearson test). (B) The expression of 46 PRLs among grades in glioma. (C) The expression of 46 PRLs between molecular subtypes. (D) The expression of 46 PRLs between normal tissues and glioma tissues. *p < 0.05, **p < 0.01, ***p < 0.001.